Preannounced Inspections Will Not Limit Investigator Authority, FDA Says
This article was originally published in The Tan Sheet
Executive Summary
Planned preannounced inspections for drugs and biologics manufacturing facilities will not compromise the authority of agency inspectors to conduct thorough inspections, FDA says in a Nov. 17 notice.